Puluo Pharmaceuticals: Plans to invest 10 million yuan to establish a biotechnology company, constituting a related party transaction.

Puro Pharmaceutical announced that on July 15, the company signed an investment agreement with Hengdian Limited Company, Zhenyutai, Boyutai, and Yuanyutai to jointly invest 10 million yuan to establish Zhejiang Antai Yutai Biotechnology Co., Ltd. The company plans to subscribe for 3.4578 million yuan, accounting for 34.578% of the shares. Because Hengdian Limited Company, Zhenyutai, Boyutai, and Yuanyutai are related parties of the company, this investment constitutes a related party transaction. The transaction does not require approval from the board of directors or shareholders' meeting and does not constitute a major asset restructuring. From the beginning of 2026 to the date of the announcement, the total amount of related party transactions with related parties is 3.4578 million yuan.